|
Product complaint # (b)(4).Date sent to the fda: 11/20/2025 this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information was requested, the following was obtained: * were there any patient consequences? --no to date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.
|
|
It was reported that a patient underwent a laparoscopic oophorectomy for ovarian lesions on (b)(6) 2025 and suture was used.During the surgery, when the surgeon used suture to suture the skin, the suture was broken.After replacing the suture with a new one, the suturing operation continued.There were no patient consequences reported.Additional information was requested.
|